ConductScience.org, home

Paper7053487

Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.

Packer M and 4 others. N Engl J Med, 1982. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. Papers, record 7053487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7053487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
PubMed
Journal
N Engl J Med
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
104
iCite
Relative citation ratio, by iCite
4.69
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Packer MM
2Meller JJ
3Medina NN
4Yushak MM
5Gorlin RR

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
HemodynamicsMajor topic
HydralazineMajor topic
Adult
Blood Pressure
Chronic Disease
Drug Tolerance
Female
Heart Rate
Humans
Male
Middle Aged
Vascular Resistance
Vasodilator Agents

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
1-R23-HL-25055-01NHLBI NIH HHSUnited StatesR23HL250550PubMedNIH RePORTER
R23HL025055NIHNIH RePORTER

Download CSV of grants

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
6753903Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6753903PubMed
6753896Acute and chronic effects of captopril therapy in patients with refractory heart failure.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6753896PubMed
6215639Recent advances in cardiology.Postgrad Med J1982https://conductscience.org/library/papers/6215639PubMed
6137226Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.Br Heart J1983https://conductscience.org/library/papers/6137226PubMed
3924285Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3924285PubMed
3552590The role of vasodilator therapy in the treatment of severe chronic heart failure.Drugs1986https://conductscience.org/library/papers/3552590PubMed
3314956Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.Br Heart J1987https://conductscience.org/library/papers/3314956PubMed
3154305Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure.Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/3154305PubMed
3064953Clinical pharmacokinetics in heart failure. An updated review.Clin Pharmacokinet1988https://conductscience.org/library/papers/3064953PubMed
3024949The treatment of heart failure. A methodological review of the literature.Drugs1986https://conductscience.org/library/papers/3024949PubMed
2996575Controlled trial of enalapril in congestive cardiac failure.Br Heart J1985https://conductscience.org/library/papers/2996575PubMed
2946034Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?Postgrad Med J1986https://conductscience.org/library/papers/2946034PubMed
2244376Medical management of congestive heart failure.West J Med1990https://conductscience.org/library/papers/2244376PubMed
2015167Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.Br J Clin Pharmacol1991https://conductscience.org/library/papers/2015167PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7053487

GET https://conductscience.org/api/papers/v1/7053487/authors